World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
28338
World Ranking
1666
National Ranking
822

Mehul S. Suthar publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mehul S. Suthar sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 271 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mehul S. Suthar D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mehul S. Suthar sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 79 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mehul S. Suthar is affiliated with Emory University in the United States and has a significant body of research focused primarily within the field of Medicine. Their work spans several subfields including Infectious Diseases, Immunology, Animal Science and Zoology, Epidemiology, and Molecular Biology.

The scientist's research efforts are concentrated on key topics such as SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, animal virus infections studies, SARS-CoV-2 detection and testing, immunotherapy and immune responses, COVID-19 impact on reproduction, and viral gastroenteritis research and epidemiology.

Suthar has contributed to multiple scientific publications, with a selection of notable papers highlighted below:

  • Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults, 2020, New England Journal of Medicine
  • SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity, 2020, Nature Communications
  • Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination, 2020, New England Journal of Medicine
  • Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis, 2021, Nature
  • Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19, 2021, New England Journal of Medicine

The frequent co-authors collaborating with Suthar include Lilin Lai, Venkata Viswanadh Edara, Katharine Floyd, Jens Wrammert, and Meredith E. Davis-Gardner. These collaborations span numerous joint publications, signaling ongoing research partnerships.

The predominant venues for Suthar's published work feature a range of journals, reflecting the interdisciplinary nature of their research. These venues include bioRxiv (Cold Spring Harbor Laboratory), The Journal of Immunology, UNC Libraries, Nature, and Cell Reports Medicine, indicating active participation in both preprint sharing and peer-reviewed scientific communication.

Best Publications

  • Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.

    Evan J. Anderson;Nadine G. Rouphael;Alicia T. Widge;Lisa A. Jackson

  • SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

    Unknown

  • SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

    Lizhou Zhang;Cody B. Jackson;Huihui Mou;Amrita Ojha

  • Homologous and Heterologous Covid-19 Booster Vaccinations

    Unknown

  • Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

    Alicia T. Widge;Nadine G. Rouphael;Lisa A. Jackson;Evan J. Anderson

  • Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.

    Bryan A. Johnson;Xuping Xie;Adam L. Bailey;Birte Kalveram

  • Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.

    Nicole Doria-Rose;Mehul S. Suthar;Mat Makowski;Sarah O’Connell

  • A complement–microglial axis drives synapse loss during virus-induced memory impairment

    Michael J. Vasek;Charise Garber;Denise Dorsey;Douglas M. Durrant;Douglas M. Durrant

  • Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

    Lalita Priyamvada;Kendra M. Quicke;William H. Hudson;Nattawat Onlamoon

  • Rapid generation of neutralizing antibody responses in COVID-19 patients

    Mehul S. Suthar;Mehul S. Suthar;Matthew G. Zimmerman;Matthew G. Zimmerman;Robert C. Kauffman;Grace Mantus

  • Zika Virus Infects Human Placental Macrophages

    Kendra M. Quicke;Kendra M. Quicke;James R. Bowen;James R. Bowen;Erica L. Johnson;Circe E. McDonald;Circe E. McDonald

  • Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.

    Pegu, Amarendra, O’Connell, Sarah E.;Stephen D. Schmidt;O’Dell, Sijy, Talana, Chloe A.

  • Systems vaccinology of the BNT162b2 mRNA vaccine in humans.

    Prabhu S. Arunachalam;Madeleine K. D. Scott;Thomas Hagan;Thomas Hagan;Chunfeng Li

  • West Nile virus infection and immunity

    Mehul S. Suthar;Michael S. Diamond;Michael Gale

  • Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.

    Kristen W. Cohen;Susanne L. Linderman;Zoe Moodie;Julie Czartoski

  • N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection.

    Nandan S. Gokhale;Alexa B.R. McIntyre;Michael J. McFadden;Allison E. Roder

  • Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection

    Stephane Daffis;Melanie A. Samuel;Mehul S. Suthar;Michael Gale

  • Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster

    Unknown

  • IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling

    Helen M. Lazear;Alissa Lancaster;Courtney Wilkins;Mehul S. Suthar;Mehul S. Suthar

  • Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.

    Venkata-Viswanadh Edara;Benjamin A. Pinsky;Mehul S. Suthar;Lilin Lai

  • Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.

    Prabhu S. Arunachalam;Alexandra C. Walls;Nadia Golden;Caroline Atyeo

  • Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.

    Abigail Vanderheiden;Philipp Ralfs;Philipp Ralfs;Tatiana Chirkova;Amit A. Upadhyay;Amit A. Upadhyay

  • Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants

    Damon Deming;Timothy Sheahan;Mark Heise;Boyd Yount

  • IL-1β Signaling Promotes CNS-Intrinsic Immune Control of West Nile Virus Infection

    Hilario J. Ramos;Marion C. Lanteri;Gabriele Blahnik;Amina Negash

Frequent Co-Authors

Michael Gale
Michael Gale University of Washington
Jens Wrammert
Jens Wrammert Emory University
Michael S. Diamond
Michael S. Diamond Washington University in St. Louis
Bali Pulendran
Bali Pulendran Stanford University
Vineet D. Menachery
Vineet D. Menachery The University of Texas Medical Branch at Galveston
Arash Grakoui
Arash Grakoui Emory University School of Medicine
Nadine Rouphael
Nadine Rouphael Emory University
Pei-Yong Shi
Pei-Yong Shi GlaxoSmithKline (United Kingdom)
Rafi Ahmed
Rafi Ahmed Emory University
Steven E. Bosinger
Steven E. Bosinger Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related online degrees in nursing can open diverse career pathways. Advanced practice nursing roles, such as a Doctor of Nursing Practice (DNP), often offer competitive salaries depending on location. Understanding how much do dnp nurses make can help students evaluate the return on investment for advanced degrees.

Nurses looking to specialize further might consider certifications that expand their scope, such as transitioning from a Family Nurse Practitioner (FNP) to an acute care nurse practitioner. Resources on acute care certification for fnp provide guidance on the necessary steps and benefits of this career shift.

For those ready to advance quickly, numerous accelerated online options exist. Many accelerated programs combine efficiency with flexibility, including recognized options described in accelerated np programs online. These programs allow students to become nurse practitioners faster without sacrificing quality.

Additionally, individuals from non-nursing backgrounds interested in entering the field can explore special online accelerated nursing programs for non nurses. These tailored pathways streamline the process of earning a nursing degree and preparing for licensure.

Best Scientists Citing Mehul S. Suthar

Trending Scientists

Recently Published Articles